miR-320a mediates doxorubicin-induced cardiotoxicity by targeting VEGF signal pathway. - Test2 - elhamkhani - TriplyDB

miR-320a mediates doxorubicin-induced cardiotoxicity by targeting VEGF signal pathway.

miR-320a mediates doxorubicin-induced cardiotoxicity by targeting VEGF signal pathway.

http://www.wikidata.org/entity/Q36601680

about

VEGF-B gene therapy inhibits doxorubicin-induced cardiotoxicity by endothelial protection.MiR-30c protects diabetic nephropathy by suppressing epithelial-to-mesenchymal transition in db/db mice.MiR-30c-5p ameliorates hepatic steatosis in leptin receptor-deficient (db/db) mice via down-regulating FASN.The role of miRNAs in cardiovascular disease risk factors.Effects of resveratrol, curcumin, berberine and other nutraceuticals on aging, cancer development, cancer stem cells and microRNAs.Role of free fatty acids in endothelial dysfunction.Sarco"MiR" friend or foe: a perspective on the mechanisms of doxorubicin-induced cardiomyopathy.Role of microRNAs in doxorubicin-induced cardiotoxicity: an overview of preclinical models and cancer patients.miRNA profiling of NurOwn®: mesenchymal stem cells secreting neurotrophic factors.MiR-124 aggravates failing hearts by suppressing CD151-facilitated angiogenesis in heart.Cardioprotective Effects of QiShenYiQi Dripping Pills on Transverse Aortic Constriction-Induced Heart Failure in Mice.MiR-665 aggravates heart failure via suppressing CD34-mediated coronary microvessel angiogenesis MiR-21 protected against diabetic cardiomyopathy induced diastolic dysfunction by targeting gelsolin

P2860

Q37469455-FE1DD4C8-BBFD-4ABD-9791-B41CC3D3FF7C Q37678211-8BBE0665-4071-42D9-B6CF-02AE86AAACBB Q37706642-87E5F887-EB5F-41AB-BB45-5CF3CBC48462 Q38815760-07CED895-25B4-41D6-A413-489DF2E5FC80 Q39370677-9F7FE973-F529-4130-9F41-1667A3749A74 Q41147225-51D46D25-7277-4028-93E6-FCB7754E498B Q41983421-71E2C45F-AA81-4061-A3CD-947187793471 Q47929107-54C386C6-EF61-4EF1-9E51-FA963A5A1287 Q49429937-C0D88F62-4E27-4EB5-A19D-BD9DAE627DE1 Q51734232-599A8AF1-9640-4BF8-8FE3-6CBF52D27C70 Q52691424-A6E6D671-69AC-425A-9A97-1055715F4D45 Q58703037-11209CF4-B2D8-42AB-901D-3DD2F3ED8766 Q58765609-2A9EC395-1413-405B-AFBB-980D15AEF320

P2860

miR-320a mediates doxorubicin-induced cardiotoxicity by targeting VEGF signal pathway.

http://www.wikidata.org/entity/Q36601680

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

miR-320a mediates doxorubicin-induced cardiotoxicity by targeting VEGF signal pathway.

@ast

miR-320a mediates doxorubicin-induced cardiotoxicity by targeting VEGF signal pathway.

@en

type

label

miR-320a mediates doxorubicin-induced cardiotoxicity by targeting VEGF signal pathway.

@ast

miR-320a mediates doxorubicin-induced cardiotoxicity by targeting VEGF signal pathway.

@en

prefLabel

miR-320a mediates doxorubicin-induced cardiotoxicity by targeting VEGF signal pathway.

@ast

miR-320a mediates doxorubicin-induced cardiotoxicity by targeting VEGF signal pathway.

@en

P1433

Q36601680-0B8A3C90-9C91-4CCF-AB14-660E4AB02D8A

P1476

Q36601680-DAD63234-E157-47C5-9719-47F9F31CA51F

P2093

Q36601680-17C94E31-F619-4546-A605-A51358885911

Q36601680-20C273FC-0B99-4D5D-B9A9-D8B77B4377FC

Q36601680-464A8BD3-6031-464E-B529-52D36DA420FB

Q36601680-4A5D292B-1DB4-4F05-AFE0-1EA6BB5500F1

Q36601680-83268742-AAE7-433D-9C23-683A19A453EA

Q36601680-88D76E2B-C94D-4623-B776-E842C7B73607

Q36601680-B75A861F-F09D-4C5F-A2A5-488D68CF6FBB

P2860

Q36601680-151DDD65-9B53-4B99-B87B-F2DF4060FA83

Q36601680-15943C9E-A9D3-4223-A1AD-8EF8D27D6DEF

Q36601680-15FA51A6-424D-476E-AA50-4408B06DF265

Q36601680-283506AC-8EE7-4F6D-9D78-0116004A5B8D

Q36601680-39645AA3-490C-4FE6-9376-B125D6BC4035

Q36601680-46963726-67CA-45EC-9346-03EA41257E7B

Q36601680-49E5ED81-E3C5-4F2A-86F2-AF6847B9C962

Q36601680-4A7E91A6-62D5-4EFC-89A3-934F457CCF66

Q36601680-561F5955-CA82-4F14-9FD0-F1550C537892

Q36601680-612BF5E7-430C-416C-8BE5-0F8A831E5EC6

P304

Q36601680-12687E63-596F-4987-9C5D-F3E9ACB2492F

P31

Q36601680-D50B3AC3-C50E-41FE-801D-B6E20A6AB221

P356

Q36601680-3D1B2F13-3D27-4F07-995E-7E1E5E0C311A

P433

Q36601680-6367F61F-9F2F-4D69-9365-478383D5F086

P478

Q36601680-D42CADB5-F0E3-4AD3-AD53-817AFD6FD1F8

P577

Q36601680-A5CB6B92-49FD-4740-81FE-E76CEFF8D8E9

P698

Q36601680-29132CB8-DD17-44F9-9F79-FC7D77BEEFFA

P932

Q36601680-8F1D8A8D-C3DE-4AD6-9BD4-73B6BBDD4CF0

P356

P1433

P1476

miR-320a mediates doxorubicin-induced cardiotoxicity by targeting VEGF signal pathway.

@en

P2093

Chen Chen

http://www.w3.org/2001/XMLSchema#string

Dao Wen Wang

http://www.w3.org/2001/XMLSchema#string

Huaping Li

http://www.w3.org/2001/XMLSchema#string

Ling Zhou

http://www.w3.org/2001/XMLSchema#string

Mengwen Yan

http://www.w3.org/2001/XMLSchema#string

Yanru Zhao

http://www.w3.org/2001/XMLSchema#string

Zhongwei Yin

http://www.w3.org/2001/XMLSchema#string

P2860

Evaluation and management of patients with heart disease and cancer: cardio-oncology

Risk factors for doxorubicin-induced congestive heart failure

Control of stress-dependent cardiac growth and gene expression by a microRNA

G-protein-coupled receptor kinase interactor-1 (GIT1) is a new endothelial nitric-oxide synthase (eNOS) interactor with functional effects on vascular homeostasis.

Adriamycin-induced cardiomyocyte and endothelial cell apoptosis: in vitro and in vivo studies.

Anti-Argonaute RIP-Chip shows that miRNA transfections alter global patterns of mRNA recruitment to microribonucleoprotein complexes.

Endothelial C-type natriuretic peptide maintains vascular homeostasis.

Disparate impact of butyroyloxymethyl diethylphosphate (AN-7), a histone deacetylase inhibitor, and doxorubicin in mice bearing a mammary tumor.

Identification of the molecular basis of doxorubicin-induced cardiotoxicity.

The annexin A2 system and vascular homeostasis

P304

192-207

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/AGING.100876

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2016-01-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26837315

http://www.w3.org/2001/XMLSchema#string

P932

4761722

http://www.w3.org/2001/XMLSchema#string